Hemogenyx Pharmaceuticals LLC
1 clinical trials · Sponsor
◉ Watch Hemogenyx Pharmaceuticals LLC
| Record | Firm | Date |
|---|---|---|
| Clinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/Refractory AML (NCT06786533) | Hemogenyx Pharmaceuticals LLC | 2025-01-23 |
Track Hemogenyx Pharmaceuticals LLC automatically
Every clearance here is in the API, with alerts when new ones post.